1. Stocks
  2. OKYO Pharma Limited - Ordinary Shares - New
  3. Swot
swot-logo

OKYO Pharma Limited - Ordinary Shares - New SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

OKYO Pharma Limited - Ordinary Shares - New has 7 Strengths, 10 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Month

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

MACD crossed below zero line previous end of day

Top Losers

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Book Value Per Share deteriorating for last 2 years

RSI indicating price weakness

Top Losers

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks